It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MGRX’s FA Score shows that 0 FA rating(s) are green whileTALK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MGRX’s TA Score shows that 4 TA indicator(s) are bullish while TALK’s TA Score has 5 bullish TA indicator(s).
MGRX (@Services to the Health Industry) experienced а -28.98% price change this week, while TALK (@Services to the Health Industry) price change was -8.70% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -5.79%. For the same industry, the average monthly price growth was -11.21%, and the average quarterly price growth was +6.88%.
TALK is expected to report earnings on Feb 24, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| MGRX | TALK | MGRX / TALK | |
| Capitalization | 14.3M | 513M | 3% |
| EBITDA | -12.4M | -401K | 3,092% |
| Gain YTD | -48.347 | 0.162 | -29,878% |
| P/E Ratio | N/A | 103.67 | - |
| Revenue | 516K | 203M | 0% |
| Total Cash | 101K | 103M | 0% |
| Total Debt | 630K | N/A | - |
| MGRX | TALK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 1 day ago 82% |
| Stochastic ODDS (%) | 2 days ago 89% | 1 day ago 64% |
| Momentum ODDS (%) | 2 days ago 77% | 1 day ago 75% |
| MACD ODDS (%) | 2 days ago 84% | 1 day ago 85% |
| TrendWeek ODDS (%) | 2 days ago 87% | 1 day ago 84% |
| TrendMonth ODDS (%) | 2 days ago 88% | 1 day ago 81% |
| Advances ODDS (%) | 13 days ago 90% | 15 days ago 77% |
| Declines ODDS (%) | 9 days ago 85% | 1 day ago 88% |
| BollingerBands ODDS (%) | 2 days ago 88% | 1 day ago 90% |
| Aroon ODDS (%) | N/A | 1 day ago 85% |
A.I.dvisor tells us that MGRX and TXG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MGRX and TXG's prices will move in lockstep.
| Ticker / NAME | Correlation To MGRX | 1D Price Change % | ||
|---|---|---|---|---|
| MGRX | 100% | -2.34% | ||
| TXG - MGRX | 25% Poorly correlated | +0.64% | ||
| TALK - MGRX | 23% Poorly correlated | -0.48% | ||
| SAP - MGRX | 22% Poorly correlated | -0.01% | ||
| LIDR - MGRX | 22% Poorly correlated | -8.84% | ||
| UBER - MGRX | 21% Poorly correlated | -1.46% | ||
More | ||||